Genscript USA Inc — Federal Contractor Profile
GENSCRIPT USA INC: $65,217 in Federal Contracts with No Recent Activity
Contractor Overview
Total Contract Value: $65,217 ($65.2K)
Total Awards: 4
Company Profile
GENSCRIPT USA INC is a federal contractor with a total government contract value of $65,217.06, involving four contracts averaging $16,304 each. The company has not won any recent contracts, and there are no specific agencies listed as clients. GENSCRIPT USA INC does not have a history of sole-source contracts, indicating a preference for competitive bidding. The company's core capabilities and specializations are not clearly defined from the available data, but it appears to be involved in various aspects of government support services. The lack of recent contracts and detailed information about their specializations and client relationships suggests a need for further investigation to understand their role and impact in the federal contracting landscape.
Specializations
- Biotechnology
- Genetic Research
- Biological Products
- Contract Research Services
- Custom Synthesis
Contractor Metrics
Average Contract Size: $0
Competitive Win Rate: 100%
Agency Concentration: moderate
Growth Trajectory: stable
Sole Source Rate: 0%
Recompete Rate: 50%
Competitive Position
GENSCRIPT USA INC appears to be a niche player in the biotechnology and genetic research sectors, with a focus on custom synthesis and contract research services. The company's preference for competitive bidding suggests a strong market position and the ability to compete effectively against other contractors in its specialty areas. However, the lack of recent contracts and detailed information about their specializations and client relationships makes it challenging to assess their market dominance or niche status.
Value to Taxpayers
While GENSCRIPT USA INC has not won any recent contracts, the average contract size of $16,304 suggests that the company is involved in smaller-scale projects. The absence of sole-source contracts indicates that the company is willing to compete, which could be seen as a positive for taxpayers. However, the lack of detailed information about their specializations and performance history makes it difficult to fully assess whether the company provides good value for the taxpayer's money.
Agency Relationships
The lack of specific agency clients and recent contracts suggests that GENSCRIPT USA INC may have a moderate level of dependency on a few agencies. Without more detailed information, it is challenging to assess the concentration risks or the reasons behind the lack of recent contracts. Further investigation into the company's client relationships and performance history would be necessary to understand the nature of their interactions with government agencies.
Red Flags
- No recent contracts: The absence of recent contracts may indicate financial or operational challenges, or it could be due to a lack of opportunities in the current market.
- Lack of detailed information: The lack of specific specializations and performance history makes it difficult to assess the company's capabilities and reliability.
- No sole-source contracts: While this is positive for competition, it may also indicate that the company is not meeting the needs of certain agencies, leading to the absence of sole-source contracts.
Green Flags
- Competitive bidding: The company's preference for competitive bidding suggests a strong market position and the ability to compete effectively against other contractors.
- Diverse contract types: The company's involvement in various contract types, such as biotechnology and genetic research, indicates a diverse range of capabilities.
- No sole-source contracts: The absence of sole-source contracts indicates that the company is willing to compete, which could be seen as a positive for taxpayers.
Key Contracts
GENSCRIPT USA INC has four contracts with a total value of $65,217.06, averaging $16,304 each. While the company has not won any recent contracts, the contracts it has secured suggest a focus on biotechnology, genetic research, and custom synthesis services. These contracts reveal that the company has the capability to provide specialized research and development services to the federal government. The lack of detailed information about the specific projects and performance history makes it challenging to assess the company's performance and strategic direction. However, the company's preference for competitive bidding and the diverse range of contract types indicate a strong market position and a willingness to compete effectively.
Frequently Asked Questions
What does GENSCRIPT USA INC do for the federal government?
GENSCRIPT USA INC provides specialized research and development services, including biotechnology, genetic research, and custom synthesis. The company's core capabilities are not clearly defined from the available data, but it appears to be involved in various aspects of government support services.
How much taxpayer money does GENSCRIPT USA INC receive?
GENSCRIPT USA INC has received a total of $65,217.06 in federal contracts, with an average contract size of $16,304. The company has not won any recent contracts, and there are no specific agencies listed as clients.
Is GENSCRIPT USA INC good value for taxpayer money?
While the average contract size of $16,304 suggests that the company is involved in smaller-scale projects, the absence of sole-source contracts indicates that the company is willing to compete, which could be seen as a positive for taxpayers. However, the lack of detailed information about their specializations and performance history makes it difficult to fully assess whether the company provides good value for the taxpayer's money.
How does GENSCRIPT USA INC win its contracts?
GENSCRIPT USA INC has a preference for competitive bidding, as evidenced by the absence of sole-source contracts. This suggests that the company is able to compete effectively against other contractors in its specialty areas. However, the lack of recent contracts and detailed information about their specializations and performance history makes it challenging to assess their competitive position.
What agencies use GENSCRIPT USA INC most?
The lack of specific agency clients and recent contracts makes it difficult to determine which agencies rely most on GENSCRIPT USA INC. Further investigation into the company's client relationships and performance history would be necessary to understand the nature of their interactions with government agencies.
What are the risks of relying on GENSCRIPT USA INC?
The absence of recent contracts and detailed information about their specializations and performance history makes it challenging to assess the risks of relying on GENSCRIPT USA INC. However, the lack of sole-source contracts and the company's preference for competitive bidding suggest that the company is willing to compete effectively, which could mitigate some risks. Further investigation into the company's client relationships and performance history would be necessary to fully understand the risks.
How does GENSCRIPT USA INC compare to similar contractors?
GENSCRIPT USA INC appears to be a niche player in the biotechnology and genetic research sectors, with a focus on custom synthesis and contract research services. The company's preference for competitive bidding suggests a strong market position and the ability to compete effectively against other contractors in its specialty areas. However, the lack of recent contracts and detailed information about their specializations and client relationships makes it challenging to fully assess their market position relative to competitors in their specialty areas.
Recent Federal Contracts
Genscript USA Inc has 2 federal contracts on record. Below are the largest awards:
| Contract | Agency | Amount | Type |
|---|---|---|---|
| FDA awards $24.1M for 242 peptides, with GenScript USA Inc. securing the cont... | Department of Health and Human Services | $24.1K | N/A |
| USDA Awards $8,485 for Custom Rodent Monoclonal Antibodies to GenScript USA Inc. | Department of Agriculture | $8.5K | N/A |